Table 2 Type of contrast, procedures and indications
Type of contrast used | Totala | Clariscan | Dotarem | Gadovist |
|---|---|---|---|---|
n (%) | 2118 (100) | 1513 (71.4) | 356 (16.8) | 237 (11.2) |
Type of indication, n (%) | ||||
CNS | 902 (42.6) | 597 (39.5) | 169 (47.5) | 130 (54.9) |
Organ/whole body | 1186 (56.0) | 900 (59.5) | 181 (50.8) | 99 (41.8) |
Angiography indication | 30 (1.4) | 16 (1.1) | 6 (1.7) | 8 (3.4) |
Type of procedure, n (%) | ||||
MRI | 1989 (93.9) | 1427 (94.3) | 345 (96.9) | 208 (87.8) |
CNS | 811 (38.3) | 529 (35.0) | 165 (46.3) | 113 (47.7) |
Organ/whole body | 1178 (55.6) | 898 (59.4) | 180 (50.6) | 95 (40.1) |
MRAb | 129 (6.1) | 86 (5.7) | 11 (3.1) | 29 (12.2) |
Organ under examination, n (%) | ||||
Brain/meninges/spinal cord | 902 (42.6) | 597 (39.5) | 169 (47.5) | 130 (54.9) |
Breast | 242 (11.4) | 178 (11.8) | 43 (12.1) | 18 (7.6) |
Musculoskeletal system | 237 (11.2) | 214 (14.1) | 14 (3.9) | 9 (3.8) |
Head and neck | 132 (6.2) | 94 (6.2) | 19 (5.3) | 16 (6.8) |
Urinary tract including bladder | 103 (4.9) | 93 (6.1) | 8 (2.2) | 2 (0.8) |
Hepatobiliary | 100 (4.7) | 63 (4.2) | 26 (7.3) | 11 (4.6) |
Genital tract including gonads | 63 (3.0) | 34 (2.2) | 12 (3.4) | 17 (7.2) |
Gastrointestinal tract | 56 (2.6) | 41 (2.7) | 10 (2.8) | 5 (2.1) |
Pancreas | 35 (1.7) | 27 (1.8) | 6 (1.7) | 2 (0.8) |
Cardiovascular | 24 (1.1) | 11 (0.7) | 9 (2.5) | 4 (1.7) |
Renal | 17 (0.8) | 16 (1.1) | 1 (0.3) | |
Endocrine glands | 16 (0.8) | 12 (0.8) | 4 (1.1) | |
Other | 191 (9.0) | 133 (8.8) | 35 (9.8) | 23 (9.7) |